Fermenta Biotech Ltd.
BSE: 506414 | Sector: Health care |
NSE: N.A. | ISIN Code: INE225B01021 |
BSE 00:00 | 24 May | 198.50 |
2.70 (1.38%) |
OPEN
197.00 |
HIGH
205.00 |
LOW
195.00 |
NSE 05:30 | 01 Jan | Fermenta Biotech Ltd Not listed in NSE |
OPEN | 197.00 |
PREVIOUS CLOSE | 195.80 |
VOLUME | 7627 |
52-Week high | 370.00 |
52-Week low | 190.15 |
P/E | 18.94 |
Mkt Cap.(Rs cr) | 584 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Fermenta Biotech Ltd.
Promoted by a technocrat D V K Raju Duphar-Interfran (DIL) was incorporated in May '51 as International Franchises Pvt Ltd. In the initial years the company manufactured and sold toothpaste anti-septic lotion and pharmaceutical specialities on a loan-licence basis. It entered into collaborations with Philips-Duphar Amsterdam (Solvay Duphar) and the Crookes Laboratories London. These collaborators ...> More
Fermenta Biotech Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
584 | |
EPS - TTM | (![]() |
[*S] | 10.48 |
P/E Ratio | (X) | [*S] | 18.94 |
Face Value | (![]() |
5 | |
Latest Dividend | (%) | 50.00 | |
Latest Dividend Date | 25 Aug 2021 | ||
Dividend Yield | (%) | 1.25 | |
Book Value / Share | (![]() |
[*S] | 131.16 |
P/B Ratio | (![]() |
[*S] | 1.51 |
Announcement
-
Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window
-
Newspaper Publication Regarding Dispatch Of Postal Ballot Notices Dated May 10 2022
-
Outcome Of Board Meeting - Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) R
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure
Fermenta Biotech Ltd - Financial Results
Particulars (![]() |
Dec 2021 | Dec 2020 | % Chg |
Net Sales | 92.86 | 89.99 | 3.19 |
Other Income | 1.16 | 0.69 | 68.12 |
Total Income | 94.03 | 90.68 | 3.69 |
Total Expenses | 90.65 | 67.79 | 33.72 |
Operating Profit | 3.37 | 22.89 | -85.28 |
Net Profit | -8.34 | 9.83 | -184.84 |
Equity Capital | 14.42 | 14.42 | - |
Fermenta Biotech Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Bliss GVS Pharma | 70.90 | -0.98 | 735.94 |
SMS Pharma. | 86.85 | 0.40 | 735.62 |
Guj. Themis Bio. | 421.10 | -4.07 | 611.44 |
Fermenta Biotec. | 198.50 | 1.38 | 584.38 |
Nectar Lifesci. | 25.40 | -0.59 | 569.72 |
Lincoln Pharma. | 280.25 | -1.63 | 561.34 |
Windlas Biotech | 223.30 | -0.71 | 486.79 |
Fermenta Biotech Ltd - SHAREHOLDING PATTERN
|
|
Fermenta Biotech Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.51% | NA | -0.49% | -0.83% |
1 Month | -15.13% | NA | -5.50% | -6.10% |
3 Month | -15.64% | NA | -0.88% | -0.76% |
6 Month | -27.78% | NA | -7.35% | -7.41% |
1 Year | -38.97% | NA | 6.71% | 6.10% |
3 Year | -5.11% | NA | 37.07% | 36.15% |
Fermenta Biotech Ltd - STOCK STRENGTH
Today's Low/High | 195.00 | 205.00 | |
Week Low/High | 190.15 | 205.00 | |
Month Low/High | 190.15 | 237.00 | |
YEAR Low/High | 190.15 | 370.00 | |
All TIME Low/High | 3.12 | 442.00 |
Quick Links for Fermenta Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices